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Abstract
Background: Neuronal regeneration in the adult mammalian central nervous system (CNS) is severely
compromised due to the presence of extrinsic inhibitory signals and a reduced intrinsic regenerative capacity. In
contrast, the CNS of adult Lymnaea stagnalis (L. stagnalis), a freshwater pond snail, is capable of spontaneous
regeneration following neuronal injury. Thus, L. stagnalis has served as an animal model to study the cellular
mechanisms underlying neuronal regeneration. However, the usage of this model has been limited due to
insufficient molecular tools. We have recently conducted a partial neuronal transcriptome sequencing project and
reported over 10,000 EST sequences which allowed us to develop and perform a large-scale high throughput
microarray analysis.
Results: To identify genes that are involved in the robust regenerative capacity observed in L. stagnalis,w e
designed the first gene chip covering ~15, 000 L. stagnalis CNS EST sequences. We conducted microarray analysis
to compare the gene expression profiles of sham-operated (control) and crush-operated (regenerative model)
central ganglia of adult L. stagnalis. The expression levels of 348 genes were found to be significantly altered (p <
0.05) following nerve injury. From this pool, 67 sequences showed a greater than 2-fold change: 42 of which were
up-regulated and 25 down-regulated. Our qPCR analysis confirmed that CCAAT enhancer binding protein (C/EBP)
was up-regulated following nerve injury in a time-dependent manner. In order to test the role of C/EBP in
regeneration, C/EBP siRNA was applied following axotomy of cultured Lymnaea PeA neurons. Knockdown of C/EBP
following axotomy prevented extension of the distal, proximal and intact neurites. In vivo knockdown of C/EBP
postponed recovery of locomotory activity following nerve crush. Taken together, our data suggest both somatic
and local effects of C/EBP are involved in neuronal regeneration.
Conclusions: This is the first high-throughput microarray study in L. stagnalis, a model of axonal regeneration
following CNS injury. We reported that 348 genes were regulated following central nerve injury in adult L. stagnalis
and provided the first evidence for the involvement of local C/EBP in neuronal regeneration. Our study
demonstrates the usefulness of the large-scale gene profiling approach in this invertebrate model to study the
molecular mechanisms underlying the intrinsic regenerative capacity of adult CNS neurons.
Background
Injuries of the central nervous system (CNS) can lead to
devastating and irreversible loss of function because
adult mammalian CNS neurons have a limited regenera-
tive capacity [1-5]. This is partially due to an age depen-
dent reduction in the intrinsic regenerative potential of
CNS neurons [6-9]. In contrast, some adult invertebrate
neurons are capable of spontaneous regeneration follow-
ing injury [10,11]. Lymnaea stagnalis (L. stagnalis)h a s
served as a critical model system to study nerve regen-
eration because of its ability to spontaneously regenerate
and restore function in the adult [12-16]. Specifically,
identified adult Lymnaea neurons can be isolated indivi-
dually and maintained in culture, allowing for axonal
outgrowth and functional synapse formation between
appropriate synaptic partners [17-19]. L. stagnalis neural
genes include homologues of well known transcription
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dance and signalling pathways [20]. Taking advantage of
this model system, a number of groups demonstrated
the roles of neurotrophins [14,21], and neurotransmit-
ters [12,22] on neurite outgrowth and regeneration.
Moreover, retinoic acid (RA) isomers have been identi-
fied in adult Lymnaea neurons, and 9-cis-RA has a
novel role in chemoattraction and growth cone guidance
[23-25]. Since many molecular mechanisms are con-
served across species, the identification of molecules
involved in neuronal regeneration in L. stagnalis will aid
our understanding of factors which may promote regen-
eration in the mammalian CNS.
One main limitation of using L. stagnalis in genetic
functional studies of neuronal regeneration has been a
lack of large-scale screening tools, such as microarray
analysis [26,27]. To circumvent this limitation, we have
recently sequenced more than 10, 000 ESTs (expression
sequence tags) from the CNS transcriptome of L. stag-
nalis [20] and established the largest neuronal EST data-
base in Lymnaea (http://www.lymnaea.org). In
combination with the availability of the microarray tech-
nology [28,29], these gene sequences provide us with
the opportunity to perform a high-throughput screening
for altered gene expression levels following nerve injury
in L. stagnalis. In this study, we have designed the first
microarray chip covering 10, 333 known L. stagnalis
genes to profile the gene expression patterns following
CNS injury. We identified 348 genes that were differen-
tially regulated following CNS crush. Using real-time
PCR (qPCR) analysis we confirmed that the gene
expression level of CCAAT enhancer binding protein
(C/EBP), a transcription factor, is up-regulated following
nerve injury. Knockdown of C/EBP following axotomy
of cultured PeA cells lead to retraction of the distal,
proximal and intact neurites. Our data suggest that C/
EBP plays a crucial role in neuronal regeneration of
Lymnaea neurons via both somatic and local
mechanisms.
Results
CNS injury model of L. stagnalis
In order to profile the gene expression pattern following
injury of the central nervous system, we modified an
established [12,14] nerve injury model by crushing the
right parietal (RPa) and right cerebral nerves (RCe) (Fig-
ure 1A). In control groups, sham operations were per-
formed without nerve injury.
Identification of differentially expressed genes
To search for genes that may be involved in neuronal
regeneration or degeneration, microarray analyses were
carried out to compare the gene expression levels
between the sham-operated and crush-operated CNS
models (Figure 1A, inset). We used an unpaired t-test
for comparison of the 15,000 array signals between two
groups: sham- and crush-operated groups. This analysis
resulted in the selection of 348 genes or ESTs (See
Additional File 1) that were differentially regulated 3
hours following CNS injury (p < 0.05). Further screening
for genes with a fold-change > 2 resulted in a final
group of 67 differentially expressed genes. Figure 1B
shows a heat map representing the hierarchical cluster-
ing of the 67 genes with significant differential expres-
sion levels between the control and injured groups.
Overall, more genes were up-regulated (n = 42) than
that of which were down-regulated (n = 25), suggesting
that diverse regulatory pathways and biological pro-
cesses are activated within the first 3 hours following
injury (Figure 1C1). Among the 67 regulated genes, 16
have been identified with known functions related to
development, survival or signal transduction; the func-
tions of the majority of genes (51) have not yet been
described (Figure 1C2).
Gene expression levels of C/EBP change in a time-
dependent manner following injury
The microarray analysis indicated that the mRNA level
of CCAAT enhancer binding protein, C/EBP, was signif-
icantly increased 3 hours following CNS injury, as com-
pared to the sham control group. A protein sequence
alignment of C/EBP orthologues from L. stagnalis, Aply-
sia, rat, and human revealed that C/EBP has a high
homology in the DNA-binding domain, suggesting that
C/EBP may have similar biological functions in these
species (Figure 2). To confirm that C/EBP is indeed up-
regulated following nerve injury at 3 hours, we per-
formed conventional RT-PCR analysis. We found that
the expression level of C/EBP mRNA significantly
increased, compared to the control gene GAPDH, in the
i n j u r e dC N Sg r o u p( 2 . 3 5±0 . 2 6f o l d ;n=5 ,p<0 . 0 5 )
over the sham groups (Figure 3A).
To study its temporal expression pattern, we further
measured the gene level of C/EBP at 1 hour, 3 hours
and 5 hours post CNS injury using qPCR analysis. The
standard curves for C/EBP are shown in Figure 3B with
a slope of -3.52, indicating the PCR efficiency for the
primers are sufficient (Figure 3B). To visualize the gene
expression level between the injured and sham groups,
the threshold cycles (Ct) of C/EBP (the target gene) and
GAPDH (the control gene) were plotted against each
other, as described previously [30]. Figure 3C shows the
representatives of Ct-Ct correlation plots between the C/
EBP and GADPH gene pair at the three different time
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Page 2 of 14Figure 1 Experimental model and changes in gene expression following injury.( A) The dorsal surface of L. stagnalis CNS and CNS injury
protocol: both right parietal (RPa) nerves and right cerebral nerves (RCe) were crushed with fine forceps. Inset: a schematic diagram of the
ganglia and location of injury (black lines). (B) Heat map representing the hierarchical clustering of 67 genes showing significant differential
expression (P < 0.05). The expression pattern of each gene in the sham and crashed groups is displayed as a horizontal strip. For each gene, the
expression ratio of the crush-operated to the sham-operated experiments is represented by the green and red scale at the bottom of the figure.
The genes are numbered on the right, and the experimental groups are labelled on the bottom. (C) Ratio of the regulated EST sequences 3 hrs
following CNS injury in L. stagnalis. (C1) The signal intensity of 348 genes or ESTs was differentially regulated. Open pie (80.7%) represents genes/
EST’s changes < 2.0-fold in signal intensity but significant (P < 0.05); grey pie (19.3%): changes ≥ 2.0-fold (P < 0.05). Dark grey: up-regulated
genes (12%), and light grey: down regulated genes (7%). (C2) Ratio of the 67 differentially regulated genes, 16 (23.8%) genes have orthologous
with known functions related to development, survival or signal transduction, whereas 51 (76.2%) genes have no orthologue.
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Page 3 of 14points (1 hr, 3 hrs, 5 hrs). The slopes of the plots were
consistent in all experimental samples, indicating the
equality in amplification efficiencies between the primers
of the gene pair. The Y-intercepts (- log(R)/log(Eg)) of
these plots were smaller in the injury group (crush) than
in the controls (sham) at all the times tested, indicating
the relative expression level of C/EBP mRNA increased
following injury. Specifically, C/EBP mRNA was initially
increased by 7.36 ± 0.73, (n = 5) at 1 hr after CNS injury,
but appeared to reduce to 2.35 ± 0.26 (n = 5) by 3 hrs
and 1.98 ± 0.75, (n = 5) by 5 hrs, albeit at levels that are
still significantly greater than in sham-operated (control)
animal (Figure 3D). These results suggest that elevation
of C/EBP mRNA expression may be necessary for tran-
scriptional induction of regeneration associated genes,
and thus likely to be a direct target of injury induced sig-
nalling cascades that promote neuronal repair.
The role of C/EBP in axonal elongation following axotomy
The increased expression of C/EBP mRNA following
nerve injury in vivo suggests that this protein may be an
upstream gene regulator of either pro-regenerative
genes or responsive genes for cell injury. To elucidate
the functional significance of C/EBP mRNA following
nerve injury, we examined the effect of C/EBP on axonal
outgrowth and regeneration of PeA neurons in culture
using a siRNA gene silencing approach as previously
described [31-33]. Axotomy was performed on cultured
PeA neurons after 24 hrs which had undergone ade-
quate neurite outgrowth (Figure 4). Immediately
following axotomy, cells were treated with either condi-
tioned medium (CM), control siRNA, C/EBP siRNA#1
or C/EBP siRNA#2. The lengths of the proximal and
distal ends of the axotomized neurite, as well as an
intact neurite were measured at various times over a
period of 36 hrs (Figure 4). The net changes of the
neurites following treatments were compared, as pre-
viously described [33]. Figure 5A shows that the distal
end axons did not show additional growth following
treatments with either C/EBP siRNA#1 (10 hrs: -0.3 ±
3.0 μm; 24 hrs: -1.8 ± 2.9 μm; 36 hrs: -5.9 ± 2.8 μm. n =
14), or C/EBP siRNA#2 (10 hrs: 1.2 ± 0.7 μm; 24 hrs:
0.1 ± 1.3 μm; 36 hrs: -3 ± 2.2 μm. n = 14) treated cells,
whereas that continuously elongated in control CM (10
hrs: 14.2 ± 2.4 μm; 24 hrs: 21.9 ± 3.1 μm; 36 hrs: 29.1 ±
3.9 μm. n = 14) or control siRNA (10 hrs: 17.6 ± 2.7
μm; 24 hrs: 21.2 ± 3.7 μm; 36 hrs: 24.4 ± 4 μm. n = 14)
treated cells following axotomy. The net changes in the
distal axons were significant between the C/EBP siRNAs
and the control CM or control siRNA groups (p < 0.05,
for all three time points). In contrast, the net increases
in length of the proximal neurites over 36 hrs are 25.6 ±
4.3 μm (n = 14) in control CM, and 23.3 ± 4.3 μm( n=
14) in control siRNA treated cells, whereas that was sig-
nificantly reduced in C/EBP siRNA #1 (10.12 ± 3.5 μm,
n = 14) or C/EBP siRNA #2 (7.2 ± 4.8 μm, n = 14) trea-
ted cells, although no significant difference was found at
the early hours (10 or 24 hrs) (Figure 5B). Similarly, the
net growth of intact neurites was only significantly
reduced in C/EBP siRNA #1 (47.4 ± 4 μm, n = 11) and
Figure 2 Protein sequence alignment of C/EBP. Amino acid alignment between CCAAT enhancer binding protein from L. stagnalis [GenBank
accession#: BAD16556], A. kurodia [GenBank#: AAG61258], R. norvegicus [GenBank#: AAI29072] and H. sapian [GenBank#: EAW75629] C/EBP. The
high degree of sequence similarity at the DNA-binding domain indicates that C/EBP has a conserved functional domain across species.
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Page 4 of 14Figure 3 Time-dependent changes in C/EBP mRNA expression following nerve injury. Real-time PCR was performed with specific primers
for C/EBP between sham-operated and crush-operated L. stagnalis CNS at 1 hr, 3 hrs, and 5 hrs post injury. (A) Relative mRNA levels of C/EBP vs
GADPH increased significantly following CNS injury as compared to the sham-operated controls at 3 hrs (2.35 ± 0.26, n = 5) (t = -3.5, df = 8, pP
< 0.05). (B) Standard curves of C/EBP and GAPDH from 6 independent samples including sham-operated and crush-operated L. stagnalis CNS at
1 hr, 3 hrs, and 5 hrs post injury. The PCR efficiency of the primers was estimated by the slope (m) = -1/log(efficiency). The expression GAPDH
was unchanged following CNS injury, and therefore CAPDH was used as an internal control. (C) Representative Ct-Ct correlation plots between
C/EBP and the control gene, GADPH, at three different time points following injury. C1: 1 hr; C2: 3 hrs; C3: 5 hrs. Relative expression ratio
between C/EBP and GADPH was estimated as Yintercept = -log(ratio)/log(efficiency C/EBP). (D) Relative gene expression of C/EBP vs. GADPH
normalized to corresponding control samples. C/EBP increased in a time-dependent manner. 1 hr: 7.36 ± 0.73 (n = 5); 3 hrs: 2.35 ± 0.26 (n = 5),
and 5 hrs: 1.98 ± 0.75 (n = 5). * indicates significant differences: ANOVA: F(2,12) = 17.4, p < 0.05. All data are presented as mean ± S.E.M.
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Page 5 of 14C/EBP siRNA #2 (42 ± 7.1 μm, n = 11) treated cells as
compared to control CM (83.9 ± 13.5 μm, n = 11) and
control siRNA treated cells (79.5 ± 5.7 μm, n = 11) 36
hrs after treatment (Figure 5C). These findings suggest
that neuronal C/EBP is involved in neurite outgrowth.
Sufficient C/EBP levels are required for maintaining the
integrity of the distal axon. Due to the application of
siRNAs following axotomy, the differences found in the
Figure 4 Knockdown of C/EBP reduced net growth of the distal, proximal, and intact neurites following axotomy. Representatives of
transected axons in culture. Immediately following axotomy (t = 0), either CM, control siRNA, C/EBP siRNA #1, or C/EBP siRNA #2 was added into
culture medium at a final concentration of 7 nM, immediately after neurite transection. The neurons were observed over additional 36 hours and
images were taken at 10, 24 and 36 hours as indicated. Arrows denote the transection site.
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esis [33,34].
C/EBP siRNA treatment hinders locomotion recovery in
vivo following CNS injury
In order to determine whether C/EBP siRNA treatment
has a role in an in vivo model, we compared the
locomotory activity of sham-operated and crush-oper-
ated snails treated with saline, control siRNA and C/
EBP siRNA#1. The distance that the snail crawled in 10
min was measured before and after nerve crush (1, 5
and 10 days post-crush), between all six groups. As
shown in Figure 6, all groups had severely movement
deficit following the nerve crush operation, but slowly
Figure 5 Differential effects of C/EBP knockdown on the distal, proximal, and intact neurites following axotomy. The length of the
distal, proximal, or intact neurite of injured cells was measured at three time points (10 hrs, 24 hrs, 36 hrs) after control or C/EBP siRNA
treatment, which was given immediately after axotomy (t = 0). (A) The distal neurite. The net changes in the C/EBP siRNA #1 or #2 treated cells
were significantly reduced as compared to that in the control CM or control siRNA treated cells (n = 14; ANOVA: at 10 hrs, F(3,52) = 14.4, p <
0.05; at 24 hrs, F(3,52) = 20.1, P < 0.05; at 36 hrs, F(3,52) = 29.7, p < 0.05). (B) The proximal neurite. A significant reduction in outgrowth was
observed only at 36 hrs after axotomy in the C/EBP siRNA #1 or #2 treated cells as compared to control CM and control siRNA treated cells (n =
14; ANOVA: F(3,52) = 5.1, p < 0.05). (C) The intact neurite. A significant reduction in outgrowth was only observed at 36 hrs in the C/EBP siRNA #1
or #2 treated cells as compared to control CM and control siRNA treated cells (n = 11; ANOVA: F(3,40) = 6.5, p < 0.05). (D) Relative gene
expression level of C/EBP vs GAPDH was significantly reduced in the C/EBP siRNA #1 (63.34 ± 8.8%) and #2 (56.25 ± 9.4%) (n = 5, ANOVA: F(2,12)
= 5.7, p < 0.05) groups as compared to control siRNA group. All data are presented as mean ± S.E.M.. * indicates p < 0.05.
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However, after 10 days, the distance (per 10 min) mea-
sured from the crush-operated C/EBP siRNA#1 group
(4.99 ± 0.71 cm, n = 3) was reduced as compared to
that from the sham-operated saline (10.28 ± 1.28 cm, n
= 6), control siRNA (12.23 ± 1.36 cm, n = 6) or C/EBP
siRNA#1 (11.56 ± 2.75 cm, n = 5), as well as to that
from the crush-operated saline (10.65 ± 2.84 cm, n = 4),
or control siRNA treated snails (10.17 ± 1.0 cm, n = 5).
These data suggest that C/EBP siRNA treatment dis-
rupted the recovery of snails following nerve injury and
support the notion that C/EBP knockdown impedes
CNS regeneration in vivo, potentially through its effects
on neurite regeneration.
Discussion
In this study, we designed the first Lymnaea gene chip
for microarray analysis and profiled the gene expression
patterns during the early stages of the CNS repair fol-
lowing injury. We found that 67 genes were significantly
regulated during the first three hours post injury,
including the conserved gene transcription factor C/
EBP. We further described the temporal gene regulation
pattern of C/EBP following CNS injury using qPCR ana-
lysis. Reduction of C/EBP mRNA level by C/EBP siR-
NAs following axotomy suppressed outgrowth of the
distal and somatic neurite in vitro at different time
points, and disrupted the recovery of locomotory func-
tion of the snails following nerve injury in vivo.O u r
data further support the notion that C/EBP is required
for nerve regeneration.
L. stagnalis has been used as a simple and reliable
model to investigate genes involved in regeneration, due
to its ability to functionally recover following CNS
injury in vivo. For example, central ganglia cell (CGC)
connections to buccal ganglia were crushed and as a
result the feeding behaviour in animals was disrupted.
Two weeks following the procedure the CGC regener-
ated, functional synapses formed between proper synap-
tic partners and the feeding behaviour was again
observed [12]. In vivo CNS regeneration was also
observed following axotomy of innervating axons to the
pneumostome and surrounding areas which prevented
the occurrence of lung respiration in 69% of snails. Sev-
eral weeks following surgery, axonal regeneration lead-
ing to the reformation of functional synapses was
Figure 6 C/EBP siRNA treatment hinders recovery of locomotion activity of the snails following CNS injury. Sham-operated or crush-
operated snails were injected with either saline, control siRNA or C/EBP siRNA. The distance that the injured snails crawled in 10 min was
measured at various time points (1 day, 5 days, and 10 days) following the nerve crush procedure. On the 10
th day, the crush-operated C/EBP
siRNA group crawled an average of 4.99 ± 0.71 cm (n = 5) per 10 min which was reduced as compared to the sham-operated saline (10.28 ±
1.28 cm, n = 6), control siRNA (12.23 ± 1.36 cm, n = 6), or C/EBP siRNA (11.56 ± 2.75 cm, n = 5), and crush-operated saline (10.65 ± 2.84 cm, n =
4) or control siRNA treated snails (10.17 ± 1.0 cm, n = 5). Data are presented as mean ± S.E.M. * indicates p < 0.05.
Aleksic and Feng BMC Neuroscience 2012, 13:2
http://www.biomedcentral.com/1471-2202/13/2
Page 8 of 14observed and pneumostome opening returned to normal
[13]. In this study, we used the modified CNS injury
model in which both the right parietal (RPa) and the
right cerebral nerves (RCe) were crushed (Figure 1A).
We are interested in the gene regulation occurring at
the early stages of CNS trauma, thus our in vivo experi-
ments were completed within 5 hours following injury.
The ability to profile the expression of thousands of
genes simultaneously makes microarrays an invaluable
biomedical research tool [35]. A previous study used
microarray approach to assess the genes involved in
anti-inflammatory responses in a spinal cord injury
model [28]. The anti-inflammatory response is an
important component of secondary tissue damage fol-
lowing spinal cord injury. The microarray study allowed
for identification of a conserved novel regulator of
regeneration, and provided a new mechanism by which
to initiate the regenerative response [29]. However,
shortcomings of microarray analysis are associated with
poor reliability [35-38] and specificity [35]. Due to the
inherent sources of error in microarray technology, it is
necessary to confirm the findings using an independent
methodology from separate samples. Real-time quantita-
tive PCR is a readily used technique to confirm microar-
ray data [39-41]. In our study, we conducted qPCR
analysis using different samples and verified that the
expression of C/EBP was indeed up-regulated following
nerve injury.
Recovery from nerve injury and neuronal regeneration
are time-dependent events, from the initial inflammatory
response to the development of the glial scar [42].
Inflammation, neurotransmitter dysfunction, ionic
imbalance, cytoskeletal alteration and increased tran-
scription occur as early as 3 hrs following spinal cord
injury [41,43,44]. Nerve outgrowth and regeneration can
be enhanced by steroids during a critical window within
the first 6 hrs after nerve injury [45]. In the C. elegans,
axons regenerate following axotomy in vivo and by 24
hrs fully functional synapses are formed [46]. We have
recently demonstrated that L. stagnalis regeneration
post injury in vitro c a nb es e e na se a r l ya s3h r s ,a n d
reformation of connections between the proximal and
distal axon is observed by 24 hrs [47]. Deducing the
gene regulation during the early response following neu-
ronal injury is important in uncovering the molecular
basis of neuronal regeneration. In this study, our micro-
array gene expression analysis identified 67 genes that
were significantly regulated following CNS injury in L.
stagnalis. We examined C/EBP gene expression at three
different time points (1 hr, 3 hrs, 5 hrs) in order to
understand how it is regulated temporally in the early
stages of recovery and repair. Our results indicated that
the C/EBP gene was up-regulated in a time-dependent
manner following CNS injury (Figure 3). We further
showed the locomotory activity of the control snails was
severely disrupted immediately following nerve injury
but recovered gradually over 10 days. C/EBP siRNA
application prior to the nerve crush procedure disrupted
the recovery of locomotory function of the snails (Figure
6), suggesting that C/EBP is required for nerve regenera-
tion in vivo. Although our in vitro data suggest that suf-
ficient C/EBP levels in neurons are required for axonal
outgrowth, it is possible that an increased C/EBP
expression in non-neuronal (phagocytic) cells involved
in nerve regeneration and inflammatory responses also
contributes to the observed recovery of locomotory
activity in the injured snails.
C/EBPs belong to the basic leucine zipper DNA bind-
ing protein family and are transcription factors with
diverse cellular roles, including regulating cell growth,
differentiation, learning and memory, and apoptosis
[48-50]. C/EBPs are also responsive to brain injury and
ischemia [51,52]. Six isoforms of C/EBP have been
found in mammals [53]. C/EBPb is highly homologous
to Lymnaea C/EBP (LC/EBP) [54]. C/EBPb was first
identified as a mediator of the inflammatory response
and IL-6 signalling through its binding to IL-6 response
elements in the promoters of acute phase response
genes TNF, IL-8, and G-CSF [55]. C/EBP expression is
enriched in neurons. It is up-regulated following brain
injury in various neuronal regenerative animal models
[56-58]. Its expression is regulated by transcription fac-
tors such as CREB and NFIL-3 [59-61]. Aplysia nerve
injury activates axoplasmic kinase, RISK-1, which phos-
phorylates apC/EBPb and initiates the binding of apC/
EBPb to the ERE enhancer site in vitro. Increases in
RISK-1 and apC/EBP were detected in injured neurons
[59]. In leech, C/EBP mRNA was increased during neu-
ronal regeneration [60]. In this study, we show that C/
EBP mRNA expression is increased following CNS
injury in a time-dependent manner. The 7-fold increase
in C/EBP mRNA at 1 hr following injury is likely related
to the inflammatory response. The sustained 2 fold
increase over the 5 hr period suggests that C/EBP may
be essential for transcriptional induction of regeneration
associated genes. Knockdown of C/EBP mRNA expres-
sion following axotomy by target-gene siRNA caused a
reduction in neurite outgrowth in both distal and proxi-
mal axons at different time points. Due to that siRNAs
were applied following axotomy, our data of C/EBP siR-
NAs causing suppression of distal neurites suggests that
local C/EBP mRNA is likely involved in neuronal regen-
eration/elongation. In contrast to the distal section of
neurites which may rely on local protein synthesis to
grow, the cell somata may continuously provide compli-
mentary mechanisms to sustain C/EBP levels and main-
tain neurite properties. The delayed effect of C/EBP
siRNAs on the proximal regrowth (Figure 5B) further
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regeneration.
CEBP-1, a member of the C/EBP family in the C. ele-
gans, is a direct effecter of the DLK-1 cascade [34].
CEBP-1 mRNA has been found in axons and presynap-
tic regions, and is stabilized via its 3’UTR by activation
of the dual-leucine zipper Kinase-1 (DLK-1) pathway
[34]. The role of C/EBP in axon regeneration is sug-
gested via dual-leucine zipper kinase MAPKKK (DLK-
1)-dependent pathway [34]. Neuronal regeneration
associated proteins such as a-tubulin and GAP-43, are
transcriptional targets of C/EBP [48,56,62]. Following
nerve injury, up-regulation of C/EBPb mRNA and C/
EBP phosphoprotein coincides with increases in the
transcription of the a-tubulin promoter in the wild-
type but not in C/EBPb
-/- mice [56]. DLK-1 acts in a
MAPK cascade with MAPMKKK-4 and p38 kinase
[63]. Both the DLK-1 pathway and CEBP-1 were neces-
sary for regenerative growth of adult touch neurons
[34]. We thus proposed a model by which the DLK-1
pathway regulates C/EBP mRNA stability in both distal
and proximal axons. Both somatic and local C/EBP
levels are required for the regenerative properties of
snail neurons (Figure 7). Local protein synthesis has
been shown to increase in injured axons and thus play
an important role in the regeneration-degradation pro-
cess [64-66]. Our study provided the first evidence that
not only the somatic but also local regulation of C/EBP
mRNA in axons is important for outgrowth and regen-
eration in L. stagnalis.
Conclusions
This is the first microarray study in L. stagnalis,a l l o w -
ing us to identify genes that are differentially regulated
following CNS injury. These genes may be involved in
regeneration and provide a new database for the study
of specific proteins and genes in response to CNS injury.
We also identified the role of the transcription factor C/
EBP in neuronal regeneration following axotomy of
adult neurons in vitro, and provided new insights into
the potential targets for CNS injury.
Methods
Animals
Fresh water pond snails, L. stagnalis,w e r eo b t a i n e d
from culture at the Free University, Amsterdam, and
maintained in the laboratory under standard conditions
at the University of Toronto [31,32]. All animals used
were kept in water at 20°C under a 12 hour light: dark
cycle, and fed green leaf lettuce twice a week. Two-
month old animals having a shell length of ~20 mm
were used for the experiment.
Surgical procedures and in vivo nerve injury
Snails were anesthetized by injecting 0.5 - 1 ml of 60
mM MgCl2 into the foot. In sterile snail saline contain-
ing (in mM): NaCl 51.3; KCl 1.7; CaCl2 4.1; MgCl2 1.5
(pH was adjusted to 7.9 with 1 mM HEPES/NaOH) a
small incision was made in the dorsal head region and
pinned open, exposing the cerebral and buccal ganglia.
In the crush-operated animals, all right parietal and cer-
ebral nerves were crushed using forceps [12]. Sham-
operated animals were operated in the same way as the
crush-operated groups, except that the right parietal and
cerebral nerves were not crushed. Following the opera-
tion, both the sham-operated and crush-operated ani-
mals were maintained under standard laboratory
conditions.
RNA extraction and cDNA synthesis
Snails were anesthetized with 10% (v/v) Listerine for 10
min, following which the CNS including the buccal gang-
lia were dissected out for total RNA extraction at 1 hr, 3
hrs or 5 hrs post-injury. For the microarray there were 4
groups of sham-operated and 4 groups of crush-operated
animals each with 2 snails per group. For RT-PCR 5 new
groups of crush-operated and 5 new groups of sham-
operated snails were used with 2 snails per group. We
used TRIzol reagent and a modified protocol (Invitrogen,
USA). 100 μl of Trizol was used per two excised CNS
and buccal ganglia, and the final pellet was resuspended
in 10 μl of RNase free water. RNA quality was checked
on an agarose gel prior to cDNA synthesis and RNA con-
centration was measured using spectrophotometry. First
strand synthesis of cDNA was conducted using Super-
Script III reverse transcriptase (Invitrogen, USA) with
random hexamer primer (Fermentas, USA) in a reaction
volume of 20 μlf o r1μg of total RNA.
cDNA Microarray
A microarray chip was designed based on the L. stagna-
lis CNS EST database http://www.Lymnaea.org/. The 15
K gene chip (cat#: G2509F) was made by Agilent Tech-
nologies (U.S.A). Briefly, the array contained a total of
15,000 spots, 10,333 probes were from unique EST/
nucleotides and 4,425 probes included different
sequences from the duplicate genes, and 50 technical
replicates with 9 replicates per probe. The hybridization
was performed by the University Health Network
M i c r o a r r a yC e n t r e( T o r o n t o ,C a n a d a ) .O n e - C o l o r
Microarray-based Gene Expression Analysis (Agilent
technologies) with cyanine 3-labeled targets was used to
measure gene expression in experimental and control
samples. Briefly, 500 μg of total RNA were amplified
using a Fluorescent Linear Amplification Kit (Agilent
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to the L. stagnalis cDNA microarray at 65°C for 17
hours. The images were scanned using a Genepix 4000B
microarray scanner (Axon Instruments, Foster City, CA,
USA). Image analysis, spot quality control and normali-
zation were performed using the Feature Extraction soft-
ware 9.5.3 from Agilent Technologies. The intensity files
were loaded into GeneSpring GX 10.0.2 software (Agi-
lent Technologies), a 75th percentile signal value was
used to normalize Agilent one-color microarray signals
for comparisons between arrays. The signals were log 2
transformed, and the median of the replicated probes
was obtained. An unpaired t-test was performed and p
< 0.05 was used as a cutoff; from these results we used
a2 . 0 - f o l dc h a n g ei ns i g n a li n t e n s i t ya sac u t o f fl i n et o
consider the differential expression of a gene as
significant.
Real-time quantitative PCR (qPCR)
Real-time PCR was performed using 5 μlo fS Y B R
Greener Reagent System (Invitrogen), added to 1 μlo f
the appropriate primer set, and a diluted sample of
cDNA that was topped off with DEPC water to a final
volume of 10 μl. For the qPCR validation and time-
c o u r s ean e ws e to fR N As a m p l e sf r o ms h a ma n d
crush-operated snails was used. Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) has been used as a com-
mon control gene for spinal cord injury models [40,67],
and its expression was unchanged following CNS injury
in L. stagnalis, therefore, we used it as an internal con-
trol (Figure 3B). The cycling parameters were: 95°C/5
min, 40 cycles of 95°C/0.5 min, 55°C/1 min, followed by
a melting curve protocol. The primer sequences used in
the study are as follows: GAPDH 5’CTGCTGATG
CCCCTATGTTTG/5’GTTGGTGGTGCAAGACTG-
CATT; C/EBP 5’CCTCTCATACATCTCCAAGTGC/
5’GAGATGTTAGGGTGTAGGAATGG.
Changes in gene expression levels following CNS
injury were determined using Ct-Ct plots [30], this ana-
l y s i si sam o d i f i c a t i o no ft h eΔΔCT and efficiency cor-
rection methods [68]. As described in our recent report
[30], the efficiency of the amplification is assumed to be
Figure 7 Schematic illustration of the potential mechanisms of C/EBP action in maintaining distal axon integrity following axotomy.C /
EBP mRNA is expressed in both the soma and axon [34,56]. In the soma, C/EBP functions as a transcription factor and results in the transcription
of regenerative-associated genes, such as a-tubulin and GAP-43, via a cAMP/PKA/CREB dependent signalling pathway [56]. Axon injury also
activates an ERK-dependent pathway that results in the phosphorylation of C/EBP and further activation of pro-regenerative genes [59]. In both
proximal and distal axons, C/EBP mRNA is stabilized by DLK-1 following axotomy [34]. Local protein synthesis of C/EBP in the distal axon may be
required for regeneration or to prevent degeneration of distal axons following injury.
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from all the samples are linear. Assuming that the PCR
efficiencies are independent of the sample, a Ct-Ct plot
is created by plotting the Ct (threshold cycle) values of
the test gene against the control gene. This yields a lin-
ear correlation between the gene pair and the slope (m)
of the plot is described as m = log(Ec)/log(Eg). The Y
axis of these plots is described by Ctg =m×C t c -l o g
(R)/log(Eg) ;w h e r eRi st h er e l a t i v ee x p r e s s i o nl e v e l
between the target gene (Qg)a n dc o n t r o lg e n e( Q c); Eg
is the amplification efficiency of the target gene; Ctg and
Ctc are the threshold cycles of the target gene and con-
trol gene, respectively [30]. The Y-intercept, a quotient
of - log(R)/log(Eg), is as a measure of R, because Eg is
constant. Thus, a small change in the Yint in the injury
group over the control group indicates a decrease in the
relative target-gene expression level.
siRNA construct
Based on L. stagnalis C/EBP sequence, we designed a 27-
mer siRNA using SciTools RNAi Design online software
(IDT DNA). When choosing siRNA we selected for
sequences with moderate to low G/C content, biased
towards the 3’-terminus and purposely avoided sequences
encoding the transmembrane domains [69]. The selected
sequences were then purchased from Shanghai Gene-
Pharma Co. Ltd. The sequences for each siRNA are as fol-
lows: C/EBP siRNA#1: 5’CUAACAUCUCCUACUCAU
UCCCAAA/5’UUUGGGAAUGAGUAGGAGAUGUUAG
GG; C/EBP siRNA#2: 5’GGA UUAUAGUCAACAAAC/
5’CUGCCUAGUUUGUUGACU; Control siRNA: 5’UU
CUCCGAACGUGUCACGUTT/5’ACGUGACACGUU
CGGAGAATT. For whole animal knockdown experi-
ments snails were anaesthetized with 10% (v/v) Listerine,
following which 2 μlo f2 0μM control siRNA or C/EBP
siRNA was injected into the head, above the central gang-
lia using a microlitre syringe (Hamilton Company, Reno,
NV, USA) [70]. To confirm the siRNA knockdown using
RT-PCR the ganglia were removed 48 hrs post-injection
for RNA extraction (Figure 4C).
Quantification of locomotion activity
Sham or crush operations were performed 48 hrs after
injection with either saline, control siRNA, or C/EBP
siRNA into the central ganglia region. Individual snails
were placed in a large Petri dish (10 cm diameter, 2 cm
depth) in 15 ml of water from their home aquaria. The
snails were given 5 minutes to acclimate to their envir-
onment, and then were recorded for 10 minutes using
Virtual Dub 1.9 software. The distance that each snail
has crawled in 10 min was analyzed using ImageTool
3.1 software (UTHSCSA, Texas). Locomotion was ana-
lyzed prior to the surgery, and at day 1, day 5 and day
10 post operation.
Primary cell culture
Snails were anaesthetized for 10 minutes in 10% (v/v)
Listerine, and the central ring and the buccal ganglia
were excised in snail saline containing (mM): NaCl 51.3,
KCl 1.7, CaCl2 4.1, MgCl2 1.5, HEPES 2 (adjusted to pH
7.9 using 1 mM NaOH). The ganglia was then incu-
bated in 3 mg/ml trypsin (Type III, Sigma, Ontario,
Canada) for 24 min. PeA neurons, which are involved in
locomotion [71], were identified and isolated from pedal
ganglia with gentle suction using a Sigmacote (Sigma,
Ontario, Canada)-coated fire-polished pipette (2 mm,
WPI, 1B200F) as previously described [72,73]. The neu-
rons were then placed onto a poly-L-lysine coated cul-
ture dish and maintained in diluted conditioned
medium (CM) at room temperature [72-74].
Axotomy and neurite outgrowth
PeA cells were cultured in CM at room temperature for
24 hours, allowing for sufficient neurite outgrowth.
Transection of the neurite was then performed using a
glass micropipette, controlled by a micromanipulator,
and moving it perpendicularly across the neurite until a
complete cut was observed [47,75]. Immediately follow-
ing axotomy the cells were treated with either the brain
conditioned medium (CM) or a final concentration of 7
nM C/EBP siRNA#1, C/EBP siRNA#1 siRNA or control
siRNA in a final volume of 2 ml of the CM. Images of
neurites were collected at the time of RNAi treatment (t
= 0), and over a 36 hr period at three time points (10,
24 or 36 hrs), using an inverted microscope (40× objec-
tive) (Olympus CK X41) with a digital camera (Olympus
C5050). The lengths of the proximal neurite, the distal
neurite and an intact neurite of the axotomized cell
were measured at various time points, using ImageTool
3.1 software (UTHSCSA, Texas).
Statistics
Data are presented as mean ± S.E.M. Data were imported
to Microsoft Excel or OriginPro v8 (Silverdale Scientific
Ltd., Bucks, HP, USA) for graphical presentation. Statisti-
cal significance between mean values of experimental
groups was evaluated using a Student’st - t e s tf o rt w o
groups and ANOVA with the Holm-Sidak post hoc test
for multiple comparisons, using SigmaStat 3.0 (SPSS, Chi-
cao, IL, USA). Significance was defined by probability
level of lower than p < 0.05.
Additional material
Additional file 1: The raw microarray data from 4 independent sets
of experiments. The original data obtained from microarray analysis of
the ganglionic mRNAs obtained from 4 sham-operated and 4 crush-
operated snails.. The highlighted line indicates C/EBP mRNA expression
levels. Red: indicates the genes with 2 fold changes in expression level in
crush-operated over sham-operated snails.
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